Correction: Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore

Pharmacoecon Open. 2024 Nov;8(6):961. doi: 10.1007/s41669-024-00516-4.
No abstract available

Publication types

  • Published Erratum